Literature DB >> 23370405

Different diets cause alterations in the enteric environment and trigger changes in the expression of hepatic cytochrome P450 3A, a drug-metabolizing enzyme.

Masataka Tajima1, Nobutomo Ikarashi, Shintaro Igeta, Takahiro Toda, Makoto Ishii, Yoshikazu Tanaka, Yoshiaki Machida, Wataru Ochiai, Harumi Yamada, Kiyoshi Sugiyama.   

Abstract

Changes in the expression level and activity of cytochrome P450 (CYP) in the liver are caused by various factors and affect the pharmacokinetics of drugs. The purpose of this study was to determine whether the expression of CYP3A is affected by a high-fat diet. In addition, we examined whether the type of diet given to mice could produce changes in the expression level and activity of CYP3A. Mice were fed a purified diet containing 10 kcal% lard (control group) or 60 kcal% lard (HF group) or regular mouse chow containing 13 kcal% of fat (MF group) for 4 weeks. No significant differences were observed in the hepatic CYP3A protein expression level between the HF group and the control group. The CYP3A protein expression in the MF group was significantly higher than that observed in the control group. In the MF group, the area under the curve (AUC) of intraperitoneally administered triazolam was lower. Because lithocholic acid (LCA) is known to increase hepatic CYP3A expression, the levels of Clostridium sordellii and LCA in the feces were measured. In the MF group, the levels of Clostridium sordellii and LCA were higher. It has been demonstrated that a high-fat diet does not cause any changes in hepatic CYP3A expression. In addition, the different diets caused alterations in the enteric environment, which triggered changes in CYP3A expression. Therefore, it is necessary to carefully consider the type of feed while performing animal experiments to evaluate the pharmacokinetics of drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370405     DOI: 10.1248/bpb.b12-01005

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Effects of gut microbiota on in vivo metabolism and tissue accumulation of cytochrome P450 3A metabolized drug: Midazolam.

Authors:  Masao Togao; Koji Kawakami; Jun Otsuka; Gaku Wagai; Yuki Ohta-Takada; Shoichi Kado
Journal:  Biopharm Drug Dispos       Date:  2020-07-20       Impact factor: 1.627

2.  A Bioequivalence Study of Avanafil in Healthy Chinese Male Subjects Under Fasting and Fed Conditions: Results of a Randomized, Open-Label, Single-Dose, 2-Sequence, 2-Period Crossover Study.

Authors:  Xiuhua Ren; Hengyi Yu; Xingxing Qi; Qian Chen; Jingwen Yang; Yinian Fang; Yongfang Lei; Donglin Zhang; Qin Zuo; Dong Liu
Journal:  Clin Pharmacol Drug Dev       Date:  2021-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.